Accelerate the development of your product to market – in the EU, US and Switzerland

Mirjam Cramer
Stephanie Krumholz

Kick-start your regulatory strategy with an hour of free advice.
Meet NDA at Bio-Technopark® Schlieren-Zürich, 2nd October 10:00 – 17:00.


NDA has supported more than 40% of the new medicinal products approved in Europe over the last five years and is spearheading an increasing number of successes with the US FDA and Swissmedic. Take this opportunity to tap into the expertise behind the success.

Dr. Stephanie Krumholz and Dr. Mirjam Cramer invite you to explore how a tailored drug development strategy can maximize your product’s potential value and reduce time to approval.

Book a free, 1 hour consultation to discuss your drug/device/drug-device development strategies.


Bio-Technopark® Schlieren-Zürich,
1st floor (GHZ: Gewerbe – und Handelszentrum Schlieren AG),
Wagistrasse 23, 8952 Schlieren, Zürich


2nd October 10:00 – 17:00


Book your free consultation before 28th September,

Looking forward hearing from you!